Nuvectra Corp Receivables Turnover Ratio (NVTR), from the second quarter 2019 to the second quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Nuvectra Corp  (NVTR)
 

Nuvectra Accounts Receivables Turnover Ratio from the second quarter 2019 to the second quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Nuvectra Corp's ability to collect accounts receivable sequentially worsen to 4.48, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Average collection period, for Nuvectra's accounts receivable remained unchanged at 81 days, in the Jun 30 2019 quarter.

If we take a look into Healthcare sector 395 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2019 from 2637 to 3096.

What is Receivable Turnover Ratio?
What is Nuvectra Corp Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVTR Receivables Turnover Ratio (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter
Y / Y Receivable Change -6.05 % 12.83 % 24.23 % 70.7 % 99.7 %
Y / Y Revenue Change -6.11 % 5.21 % -8.9 % 86.64 % 82.04 %
Receivable Turnover Ratio (TTM) 4.48 4.49 4.56 4.94 4.85
NVTR's Total Ranking # 3096 # 2637 # 3091 # 2596 # 2637
Accounts Receivable average collection period days 82 81 80 74 75
Seq. Receivable Change -7.96 % -16.87 % 8.16 % 13.52 % 10.54 %
Seq. Revenue Change 10.97 % 2.14 % -23.38 % 8.11 % 24.35 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 126
Healthcare Sector # 396
Overall Market # 3096

Receivable Turnover Ratio Statistics
High Average Low
9.93 6.35 4.48
(Apr 01 2016)   (Jun 30 2019)





NVTR Company Profile • Back to NVTR Efficiency Comparisons • Compare NVTR Receivables Turnover Ratio to its Competitors

Financial Statements
Nuvectra's Accounts Receivable $ 9 Millions Visit NVTR's Balance sheet
Nuvectra's Sales TTM $ 49 Millions Visit NVTR's Income Statement
Sources of NVTR's Revenues Visit NVTR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NVTR's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NVTR's Growth Rates NVTR's Roa NVTR's Inventory Turnover Ratio NVTR's Dividend Comparisons
NVTR's Profitability Ratios NVTR's Roi NVTR's Asset Turnover Ratio NVTR's Dividend Growth
NVTR's Valuation Ratios NVTR's Roe NVTR's Financial Strength Ratios NVTR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2019 Receivable at quarter ending Jun 30 2019
Corcept Therapeutics Inc  14.14 $ 268.362  Millions$ 18.985  Millions
Acadia Healthcare Company Inc   14.07 $ 4,719.665  Millions$ 335.521  Millions
Nuo Therapeutics Inc   13.85 $ 1.156  Millions$ 0.083  Millions
Mannkind Corporation  13.66 $ 52.950  Millions$ 3.875  Millions
Musclepharm Corporation  13.31 $ 83.173  Millions$ 6.251  Millions
Rigel Pharmaceuticals Inc  13.22 $ 65.753  Millions$ 4.974  Millions
Miragen Therapeutics Inc   13.00 $ 4.306  Millions$ 0.331  Millions
Talphera Inc   12.96 $ 2.196  Millions$ 0.169  Millions
Chimerix Inc   12.58 $ 8.997  Millions$ 0.715  Millions
Sutro Biopharma Inc   12.48 $ 46.076  Millions$ 3.693  Millions
Travere Therapeutics Inc   12.43 $ 168.754  Millions$ 13.578  Millions
Neuronetics Inc   12.40 $ 58.672  Millions$ 4.732  Millions
Immucell Corporation  12.21 $ 12.211  Millions$ 1.000  Millions
Akebia Therapeutics Inc   12.10 $ 286.488  Millions$ 23.669  Millions
Exact Sciences Corporation  12.03 $ 623.185  Millions$ 51.811  Millions
Otonomy Inc   11.97 $ 0.703  Millions$ 0.059  Millions
Zynex inc   11.95 $ 36.961  Millions$ 3.094  Millions
Lifeloc Technologies Inc   11.93 $ 8.513  Millions$ 0.713  Millions
Scienture Holdings Inc   11.88 $ 5.570  Millions$ 0.469  Millions
Neurometrix Inc   11.71 $ 12.873  Millions$ 1.099  Millions
Integrated Biopharma Inc  11.56 $ 49.977  Millions$ 4.324  Millions
Premier Biomedical Inc  11.35 $ 0.027  Millions$ 0.002  Millions
Rafael Holdings Inc  11.03 $ 4.931  Millions$ 0.447  Millions
Kushco Holdings Inc   10.90 $ 121.943  Millions$ 11.190  Millions
China Pharma Holdings Inc  10.77 $ 11.040  Millions$ 1.025  Millions
Teladoc Health Inc   10.71 $ 492.552  Millions$ 45.979  Millions
Therapeutic Solutions International Inc   10.67 $ 0.013  Millions$ 0.001  Millions
Procyon Corporation  10.62 $ 4.191  Millions$ 0.395  Millions
Dmk Pharmaceuticals Corporation  10.52 $ 18.658  Millions$ 1.774  Millions
Acorda Therapeutics Inc   10.51 $ 306.156  Millions$ 29.138  Millions

Date modified: 2026-09-08T15:09:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.